Kalydeco 150 MG tablet 56S
Ended Awarded
- Contract number
- SPE2DB25FAZJJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,275
Award facts
- Contract value 100% obligated
- $22,274.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,274.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Kalydeco 150 mg tablets (56-count units). This firm fixed-price delivery order was issued on July 15, 2025, with an ultimate completion date of July 16, 2025, and represents a direct distribution of pharmaceutical products supporting Department of Defense healthcare facilities. The award carries no set-aside designation, indicating that DMS Pharmaceutical Group competed openly in the federal procurement marketplace.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. Through this significant single-award IDC vehicle, the DLA maintains the ability to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including prescription medications, biologics, and medical consumables. DMS Pharmaceutical Group's positioning as a critical supplier in the federal pharmaceutical supply chain enables it to provide direct distribution of specialized medications such as Kalydeco, a cystic fibrosis treatment, to military health facilities worldwide.
Quick answers
Who was awarded contract SPE2DB25FAZJJ?
SPE2DB25FAZJJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 15, 2025.
How much is contract SPE2DB25FAZJJ worth?
The government has obligated $22,275 on SPE2DB25FAZJJ.
Is contract SPE2DB25FAZJJ an order under another contract?
Yes. SPE2DB25FAZJJ is a delivery order under SPE2DB24D9222, an indefinite delivery contract.
Was contract SPE2DB25FAZJJ competed?
The extent of competition for SPE2DB25FAZJJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award